10 articles
This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications…
This analysis explores the relationship between intellectual property, accessibility, and public health, with a focus on recent global developments amid COVID-19. It highlights key policy measures, compulsory licensing,…
The post explores the preference for collaborative and open innovation during the COVID-19 crisis, detailing the decline in IP filings and the shift away from IP exclusivity. It…
This post shares WHO’s latest COVID-19 advice, covering prevention, safety, and guidance for those in affected areas. It highlights hand and respiratory hygiene, social distancing, and the importance…
Dr. Jonas Salk developed the polio vaccine and chose not to seek a patent, enabling worldwide access and saving millions of lives. His humanitarian approach set a precedent…
This post examines compulsory licensing in India, with emphasis on the local working requirement and its interpretation under Indian patent law. It discusses the legal debates surrounding the…
This article explores the problem of smoking and passive smoking, emphasizing ongoing health risks despite legislative efforts. It also examines a patented smokeless smoking device designed to mitigate…
The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of…
The WTO has extended the waiver on pharmaceutical patent enforcement for least developed countries until 2033. This move ensures continued access to affordable generics from India and highlights…
The Indian Patent Office has revoked Roche’s Valganciclovir patent, emphasizing Section 3d and public interest. This decision strengthens access to medicines in India and curbs evergreening by pharmaceutical…